April 2, 2020 | Portfolio News

GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A